Viewing Study NCT00699166


Ignite Creation Date: 2025-12-24 @ 4:15 PM
Ignite Modification Date: 2025-12-27 @ 11:56 PM
Study NCT ID: NCT00699166
Status: COMPLETED
Last Update Posted: 2008-06-17
First Post: 2008-06-12
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Efficacy, Safety and Tolerability of DNK333 (25 and 100 mg Bid) in Women With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
Sponsor: Novartis
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module